People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cardiac Insight, Inc. | — | Biotechnology | Series A | $38.1M | $184.0M | 2022 |
Kurt Noltensmeyer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kurt Noltensmeyer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Clifford Stocks | 1 | 5 |
| Brad Harlow | 1 | 4 |
| Robert Odell | 1 | 3 |
| Richard O Martin | 1 | 3 |
| Bill Willis | 1 | 3 |
| Michael Schuh | 1 | 2 |
| Robert Hauser | 1 | 2 |
| Richard Martin | 1 | 2 |
| Kirby Cramer | 1 | 1 |
| Robert deGavre | 1 | 1 |
| Lex Gamble | 1 | 1 |
| Mike Schuh | 1 | 1 |
| Bob Odell | 1 | 1 |
| Hemanth Reddy | 1 | 1 |
| Hyoung Min Kim | 1 | 1 |
| Ann Demaree | 1 | 1 |
| David Hadley | 1 | 1 |
| Daniel Tylutki | 1 | 1 |
| Stacy Sprouse | 1 | 1 |
| David T Linker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.